Combination with lifestyle or supportive interventions (when appropriate)
Healthcare providers typically monitor hemoglobin A1c, fasting blood glucose, lipid panels, kidney function tests (creatinine, eGFR, UACR), and liver function tests to assess treatment efficacy and safety
Aniiket Sengar 18 December, 2025 Digbi Health Expands its Multi-Condition Care Platform to Enhance Tolerability and Efficacy of GLP-1 Drugs The first Precision Biology-based GLP-1 companion program, Digbi Care (), gets even better by incorporating gut microbiome and genetic biomarkers that determine tolerability and efficacy of GLP-1 drugs
Some companies limit coverage to specific providers and exclude certain medications from their formulary.
In most cases, people can continue their medication and manage the hair loss at the same time, Marmur says